GlassScriptPhysician profile
Michael Maceroli
NPI 1316236615
$384,993.17
in general payments reported to CMS, 2019-2025
10 companies · $77K in 2025
The $77K reported for 2025 was more than what 94% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,463 · 2020: $22K · 2021: $31K · 2022: $49K · 2023: $95K · 2024: $105K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $227K · Travel and Lodging: $40K · Food and Beverage: $6,168 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $227,389.50 |
| Travel and Lodging | $40,294.65 |
| Food and Beverage | $6,168.13 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $357,677.23 | 2019-2025 | Axsos, Gamma, T2 |
| Medical Device Business Services, INC. | $16,429.93 | 2019-2020 | |
| Synthes Gmbh | $7,415.98 | 2022-2025 | |
| Acera Surgical, INC. | $1,239.11 | 2024 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $1,197.69 | 2019-2024 | Na, Va-Lcp |
| Orthoxel Designated Activity Company | $500.00 | 2019 | |
| Synthes USA Products LLC | $475.69 | 2020 | |
| Smith+Nephew, INC. | $33.10 | 2019 | |
| United Orthopedics LLC | $14.53 | 2025 | |
| Illuminoss Medical, INC. | $9.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maceroli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.